I’m thrilled to announce that this Sunday, I’ll be back on the bike, donning the number #0300, as I participate in the annual Ballarat Cycle Classic. This significant event, set to take place next weekend, holds a powerful purpose – to support the Fiona Elsey Cancer Research Institute and its ambitious goal of raising $250,000. This remarkable initiative has already raised over $2.6 million for cancer research since its inception.
You might wonder why I’m taking on the challenge of cycling 85km of demanding terrain at the Ballarat Classic, especially considering my recent meniscal and ACL injury that led to limited training. The answer lies in my profound admiration for the recent strides made by the Fiona Elsey Cancer Research Institute, under the leadership of Professor Kannourakis. Their groundbreaking work involving immunomodulation therapy for aggressive cancers, particularly the biologically aggressive triple-negative breast cancer affecting up to 20% of all cases, has left me deeply inspired. I am determined to contribute to their ongoing efforts by raising crucial funds – an indispensable factor in the world of research.
By supporting my fundraising campaign, you’re directly contributing to a cause that holds personal significance. Your secure online donation and messages of encouragement are valuable beyond measure.
Triple negative breast cancer, including cases linked to the BRCA 1 mutation, poses unique challenges. These cancers do not respond to traditional Endocrine treatment due to their lack of susceptibility to hormones like estrogen, progesterone, or Her-2. Known for their aggressive nature, rapid growth, and higher risk of metastasis and recurrence, these cancers are often detected at later stages with associated poor outcomes. Lymph node disease sees a 65% survival rate, while distant disease shows a mere 12% survival over a 5-year period. Management typically involves surgery and chemotherapy, leading to compromised immunity, severe infections, and the distressing loss of body hair.
The Australian Breast Care Centre, my not-for-profit organization, advocates a mantra highly applicable to this type of cancer: “Early detection saves lives.” While we anticipate the integration of groundbreaking research into clinical practice, it’s imperative that we remain proactive in safeguarding the well-being of the women in our lives. One way to do so is by assessing your risk profile through Genetype testing.
In conclusion, I urge you to stand alongside those tirelessly working towards a cure for this disease. You can make a tangible impact by donating to the Fiona Elsey Research Institute via the link provided below. Your contributions are secure and will be directly routed to my chosen charity.